Concepedia

Julie Agriesti

JA

Statistics

Publications

8

Citations

1.1K

H-Index

8

Active since

2015

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Fondazione IRCCS Istituto Neurologico Carlo Besta

International University of Health and Welfare

University of North Carolina at Chapel Hill

Alnylam Pharmaceuticals (United States)

Julie Agriesti is an author at Alexion Pharmaceuticals (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Publications per year

2015–2023

8

Publications

8

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

, , +6

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

, , +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

, , +14

Long-term disability after lacunar stroke

Mandip S. Dhamoon, Leslie A. McClure, Carole L. White et al. · Neurology · 2015 · 38 citations · Full text

, , +16

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis

Anthony A. Amato, Michael G. Hanna, Pedro Machado et al. · Neurology · 2021 · 37 citations · Full text

, , +14

1–5 of 8